[HTML][HTML] A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis

EJ Weiss, PF Bray, M Tayback… - … England Journal of …, 1996 - Mass Medical Soc
Background Platelet glycoprotein IIb/IIIa is a membrane receptor for fibrinogen and von
Willebrand factor, and it has an important role in platelet aggregation. It is known to be involved …

Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance

…, S Guthikonda, J Granada, T DeLao, PF Bray… - Journal of the American …, 2006 - jacc.org
Aspirin and Clopidogrel Drug Response in Patients Undergoing Percutaneous Coronary
Intervention: The Role of Dual Drug Resistance Eli I. Lev, Rajnikant T. Patel, Kelly J. Maresh, …

Analysis of 13 cell types reveals evidence for the expression of numerous novel primate-and tissue-specific microRNAs

…, CA Shaw, SE McKenzie, P Bray… - Proceedings of the …, 2015 - National Acad Sciences
Two decades after the discovery of the first animal microRNA (miRNA), the number of miRNAs
in animal genomes remains a vexing question. Here, we report findings from analyzing …

Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity

…, MS Bray, SM Leal, J Dong, PF Bray - Blood, The Journal …, 2011 - ashpublications.org
MicroRNAs (miRNAs) regulate cell physiology by altering protein expression, but the biology
of platelet miRNAs is largely unexplored. We tested whether platelet miRNA levels were …

Platelet GP IIIa PlA Polymorphisms Display Different Sensitivities to Agonists

…, MR Barnard, T Kickler, DJ Christie, S Kundu, PF Bray - Circulation, 2000 - Am Heart Assoc
Background—Both inherited predisposition and platelet hyperreactivity have been associated
with ischemic coronary events, but mechanisms that support genetic differences among …

Effects of conjugated equine estrogen on stroke in the Women's Health Initiative

…, M Trevisan, A Aragaki, AE Baird, PF Bray… - Circulation, 2006 - Am Heart Assoc
Background— The Women’s Health Initiative (WHI) Estrogen Alone trial assessed the balance
of benefits and risks of hormone use in healthy postmenopausal women. The trial was …

Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study

…, P Greenland, RJ Rodabough, PF Bray… - Archives of internal …, 2005 - jamanetwork.com
Background Increasing evidence supports a role for inflammation in the atherosclerotic
process. The role of the leukocyte count as an independent predictor of risk of a first …

Sex differences in platelet reactivity and response to low-dose aspirin therapy

…, D Vaidya, LR Yanek, JE Herrera-Galeano, PF Bray… - Jama, 2006 - jamanetwork.com
ContextRecent randomized trials suggest that women may not accrue the same cardioprotective
benefits as men do from low-dose aspirin therapy used in primary prevention. Failure of …

Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions

OJT McCarty, SA Mousa, PF Bray… - Blood, The Journal …, 2000 - ashpublications.org
Accumulating evidence suggests that successful metastatic spread may depend on the ability
of tumor cells to undergo extensive interactions with platelets. However, the mechanisms …

Venous thrombosis and conjugated equine estrogen in women without a uterus

JD Curb, RL Prentice, PF Bray… - Archives of internal …, 2006 - jamanetwork.com
Background Postmenopausal hormone therapy has been associated with a 2- to 3-fold
increased risk of venous thromboembolism (VT) (including deep vein thrombosis and pulmonary …